Literature DB >> 24642923

Unsuspected cardiovascular involvement in relapsing polychondritis: a case of aortitis with critical coronary artery stenosis secondary to relapsing polychondritis.

Gavin Sugrue1, Laura Durcan, Leann Bell, Ferdia Bolster, Suzanne Donnelly, Eoin Kavanagh.   

Abstract

Entities:  

Keywords:  biological therapy; polychondritis, relapsing

Mesh：

Substances：

Year:  2014        PMID： 24642923     DOI： 10.1161/CIRCIMAGING.113.001290

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN： 1941-9651            Impact factor:   7.792


× No keyword cloud information.
  6 in total

Review 1.  Aortic involvement in relapsing polychondritis: case-based review.

Authors:  Mustafa Erdogan; Sinem Nihal Esatoglu; Gulen Hatemi; Vedat Hamuryudan
Journal:  Rheumatol Int       Date:  2019-11-25       Impact factor: 2.631

Review 2.  Relapsing polychondritis: a chameleon among orphan diseases.

Authors:  Sabine Schumacher; Herwig Pieringer
Journal:  Wien Med Wochenschr       Date:  2017-03-31

3.  (18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis.

Authors:  Wei Lei; Hui Zeng; Da-Xiong Zeng; Bin Zhang; Ye-Han Zhu; Jun-Hong Jiang; Jian-An Huang
Journal:  Br J Radiol       Date:  2015-11-03       Impact factor: 3.039

Review 4.  Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis.

Authors:  Ghassan Elourimi; Michael Soussan; Ursula Warzocha; Hélène Bugaud; Robin Dhôte; Sébastien Abad
Journal:  Rheumatol Int       Date:  2017-09-30       Impact factor: 2.631

5.  Sudden Cardiac Death due to Coronary Artery Vasculitis in a Patient with Relapsing Polychondritis.

Authors:  Heather Bukiri; Steven M Ruhoy; Jane H Buckner
Journal:  Case Rep Rheumatol       Date:  2020-11-16

Review 6.  Relapsing Polychondritis: An Updated Review.

Authors:  Francesco Borgia; Roberta Giuffrida; Fabrizio Guarneri; Serafinella P Cannavò
Journal:  Biomedicines       Date:  2018-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.